Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen Reply

Author(s):
Dezentje, V.O.; Blijderveen, N.J.C. van; Gelderblom, H.; Putter, H.; Herk-Sukel, M.P.P. van; Casparie, M.K.; Egberts, A.C.G.; Nortier, J.W.R.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2010
Publication type
Article / Letter to editor
breast-cancer
Date issued
2010-10-10
Language
English
Is part of
Journal of Clinical Oncology (2010), Vol. 28, no. 29, p. E586E586
hdl
1887/110779